# Probiotic Lactic Acid Bacteria Fermentation Modulates the Bioactive Properties of Sprouted and Unsprouted Amaranth Seed

**Authors:** Mihaela Aida Vasile, Nicoleta Balan, Leontina Grigore-Gurgu, Gabriela Elena Bahrim, Mihaela Cotârleț

PMC · DOI: 10.3390/microorganisms14020340 · Microorganisms · 2026-02-02

## TL;DR

This study shows that fermenting sprouted and unsprouted amaranth seeds with probiotic bacteria enhances their nutritional and antioxidant properties.

## Contribution

The novel aspect is the combined effect of sprouting and probiotic fermentation on the bioactive properties of amaranth seeds.

## Key findings

- Red amaranth samples showed higher levels of biologically active compounds than black amaranth.
- Fermentation with L. rhamnosus MIUG BL38 increased protein background intensity, indicating protein hydrolysis.
- Sprouting and probiotic fermentation improved the functional and biochemical properties of amaranth seeds.

## Abstract

This study aims to investigate the functional and biochemical characteristics of sprouted and unsprouted red and black amaranth flours by fermentation with four probiotic strains (Lactiplantibacillus plantarum MIUG BL21, Lactiplantibacillus pentosus MIUG BL24, Lacticaseibacillus rhamnosus MIUG BL38, and Lactiplantibacillus paraplantarum MIUG BL74). Aqueous extracts from freeze-dried fermented products derived from sprouted and raw seed of two Amaranthus species (Amaranthus cruentus—red amaranth and Amaranthus hypochondriacus—black amaranth) were characterised for their acidification and phytochemical profiles by titrimetric, spectrophotometric and chromatographic methods, and their antioxidant activities by ABTS and DPPH assays. Water-soluble proteins were evaluated by SDS-PAGE analysis. Nine phenolic acids (gallic acid, protocathechic acid, syringic acid, ellagic acid, ferulic acid, cinnamic acid, caffeic acid, p-coumaric acid, and chlorogenic acid) and twelve flavonoids (epicatechin gallate, hesperitin, quercetin, apigenin, luteolin, naringenin, quercetin 3-glucoside, isorhamnetin, peonidin 3-O rutinoside, epicatechin, keracyanin, and rutin trihydrate) were identified in the extracts of amaranth samples. The titratable acidity ranged from 0.59 to 5.50 mL of 0.1 N NaOH. Total flavonoid content (TFC) varied from 1.09 to 4.67 mg CE/g DW; whereas, total phenolic content (TPC) fluctuated from 1.99 to 5.76 mg GAE/g DW. The spectrum of ABTS and DPPH values was from 17.49 to 56.82% and 0.60 to 35.50%, respectively. More biologically active compounds were found in red amaranth-based samples, both sprouted and unsprouted, compared to black amaranth-based samples. There was a moderate correlation between the TPC and the antioxidant activity. The fermentation of red amaranth with L. rhamnosus MIUG BL38 led to a global increase in the protein background intensity, consistent with protein hydrolysis. Overall, sprouting and probiotics fermentation improved the fermentative performance of the amaranth seeds, enabling their effective use as a nutritive food with potential health-promoting properties.

## Linked entities

- **Chemicals:** gallic acid (PubChem CID 370), syringic acid (PubChem CID 10742), ellagic acid (PubChem CID 5281855), ferulic acid (PubChem CID 445858), cinnamic acid (PubChem CID 444539), caffeic acid (PubChem CID 689043), p-coumaric acid (PubChem CID 637542), chlorogenic acid (PubChem CID 1794427), epicatechin gallate (PubChem CID 65056), hesperitin (PubChem CID 72281), quercetin (PubChem CID 5280343), apigenin (PubChem CID 5280443), luteolin (PubChem CID 5280445), naringenin (PubChem CID 932), quercetin 3-glucoside (PubChem CID 5280804), isorhamnetin (PubChem CID 5281654), peonidin 3-O rutinoside (PubChem CID 90470732), epicatechin (PubChem CID 1203), keracyanin (PubChem CID 29231), rutin trihydrate (PubChem CID 16218542)
- **Species:** Amaranthus cruentus (taxon 117272), Amaranthus hypochondriacus (taxon 28502)

## Full-text entities

- **Diseases:** metabolic diseases (MESH:D008659), BA (MESH:D007898), celiac disease (MESH:D002446), RA (MESH:C562718), injury to (MESH:D014947), inflammation (MESH:D007249), diabetes (MESH:D003920), cancer (MESH:D009369), heart disease (MESH:D006331), chronic (MESH:D002908), SPC (MESH:D063466), cardiovascular, metabolic, and inflammatory diseases (MESH:D002318)
- **Chemicals:** Amaranth (MESH:D000548), hesperitin (MESH:C013015), Water (MESH:D014867), kaempferol (MESH:C006552), peptides (MESH:D010455), myricetin (MESH:C040015), iron (MESH:D007501), phenolic acid (MESH:C017616), ferulic acid (MESH:C004999), hyperoside (MESH:C021304), catechin (MESH:D002392), squalene (MESH:D013185), apigenin (MESH:D047310), Cinnamic acid (MESH:C029010), p-hydroxybenzoic acid (MESH:C038193), Laemmli buffer (MESH:C088816), epicatechin gallate (MESH:C062669), SDS (MESH:D012967), acetic acid (MESH:D019342), aglycones (MESH:C458179), hydroxybenzoic acids (MESH:D062385), Ethanol (MESH:D000431), CE (MESH:D002563), NaOH (MESH:D012972), sinapic acids (MESH:C073734), CaCO3 (MESH:D002119), phytic acid (MESH:D010833), methanol (MESH:D000432), saline (MESH:D012965), sugars (MESH:D000073893), formic acid (MESH:C030544), vanillic acid (MESH:D014641), salicylic acid (MESH:D020156), Gallic acid (MESH:D005707), Lactic acid (MESH:D019344), hydroxycinnamic acids (MESH:D003373), m-coumaric acid (MESH:C043332), quercetin (MESH:D011794), 2,2-Diphenyl-1-picrylhydrazyl (MESH:C004931), agar (MESH:D000362), Coomassie Brilliant blue G-250 (MESH:C004692), phytosterols (MESH:D010840), NaNO2 (MESH:D012977), pentose phosphate (MESH:D010428), polymers (MESH:D011108), rutin (MESH:D012431), Polyphenol (MESH:D059808), protocatechuic acid (MESH:C009091), AlCl3 (MESH:D000077410), Lp (MESH:D008070), 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (MESH:C002502), lipids (MESH:D008055), p-coumaric acid (MESH:C495469), naringenin (MESH:C005273), Na2CO3 (MESH:C005686), acetate (MESH:D000085), KCl (MESH:D011189), sodium acetate (MESH:D019346), lysine (MESH:D008239), luteolin (MESH:D047311)
- **Species:** Amaranthus caudatus (amaranth, species) [taxon 3567], Amaranthus hypochondriacus (grain amaranth, species) [taxon 28502], Amaranthus cruentus (blood amaranth, species) [taxon 117272], Phalaris canariensis (species) [taxon 376798], Lacticaseibacillus rhamnosus (species) [taxon 47715], Chenopodium quinoa (quinoa, species) [taxon 63459], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Sesamum indicum (beniseed, species) [taxon 4182], Lacticaseibacillus paracasei subsp. paracasei (subspecies) [taxon 47714], Lactiplantibacillus plantarum (species) [taxon 1590], Lacticaseibacillus casei (species) [taxon 1582], Leptospira sp. AB (species) [taxon 103236], Lactiplantibacillus plantarum subsp. plantarum (subspecies) [taxon 337330], Amaranthus (genus) [taxon 3564], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** BL74 — Homo sapiens (Human), EBV-related Burkitt lymphoma, Cancer cell line (CVCL_C158)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12943157/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12943157/full.md

## References

57 references — full list in the complete paper: https://tomesphere.com/paper/PMC12943157/full.md

---
Source: https://tomesphere.com/paper/PMC12943157